|
SoCalBio Vendor Spotlight
Ground Zero Pharmaceuticals
(Irvine)
A SoCalBio Member Since 2002
Represented in SoCalBio by its President & CEO Evan Siegel (PhD), Ground Zero Pharmaceuticals focuses on bringing medical product programs through the FDA regulatory process, from late discovery through final approval and postmarketing..... Learn more
|
Join SoCalBio
Join SoCalBio leaders to promote the biotech and device industries in Los Angeles, Orange County and neighboring communities for job creation and overall economic growth.
|  |
| Thanks to SoCalBio Media Partners
|
|
|
|
May 20, 2013
|  Editor: Ahmed Enany
President & CEO
Southern California
Biomedical Council
enany@socalbio.org
www.socalbio.org
|
|
Featured Story
|
SoCalBio Member Kite Pharmaceuticals Raises $35 Million in Series A Funding
 "We are extremely pleased with the significant level of interest in Kite and its programs by our existing investors and by Alta Partners, a premier life sciences investment firm," said Aya Jakobovits , Ph.D. (photo right), President and Chief Executive Officer of Kite Pharma. "The new resources will allow us to advance clinical and manufacturing activities of eACT products directed to hematological and solid tumor indications" ... Learn more
|
|
MARK YOUR CALENDAR
Featuring Next Gen. Medtech, Biotech & eHealth Companies To sponsor or make a business presentation, contact SoCalBio at |
|
Sponsored Event
|
SoCalBio Encourages its Membership to Attend the Following Event
think ASIA, think HONG KONG
June 14, 2013, Starting at 8:15 am
J W Marriott in Downtown Los Angeles
REGISTER NOW (Free Event)
 Organized by SoCalBio's international partner the Hong Kong Trade Development Council (HKTDC), this event is designed to promote Hong Kong as Asia's central business district, the first stop for overseas companies entering the Asian market, and the global gateway to China .
Join SoCalBio at think ASIA, think HONG KONG to tap resources that will help you succeed in Asia.. Learn more
|
| RSVP Now |
SoCalBio Networking Forum
May 30, 4 to 7 pm
Conference Room of the USC Stem Cell Research Institute at the USC Health Sciences Campus in East Los Angeles
Groundbreaking Technologies to
Reverse Blindness
Keynote Presenter
Robert Greenberg, MD, PhD
Co-Founder, President & CEO
Second Sight Product Corporation
Join us to get a glimpse of how SoCalBio members are changing the face of medicine. Learn about Second Sight's FDA-approved and first-in-breed bionic eye -- the Argus II -- that restores some vision to people suffering from Retinitis Pigmentosa.
The Argus II is:
- An example of new technologies under development in Southern California that promise to reverse blindness.
- A demonstration of the virtuous outcome of effective local university/industry collaborations
- The latest in a long string of many biomedical breakthrough innovations made in the Greater Los Angeles region since the 1930s that changed the face of medicine and improved patient care.
- Another landmark contribution to medicine by Los Angeles biomedical entrepreneur, philanthropist and SoCalBio Chairman Emeritus Alfred E. Mann.
|
|
Awards
|
HHS Offers $1 Billion for Healthcare Innovation Grant Awards to Provide Better Healthcare and Lower Costs
 "Organizations from the public and private sectors throughout the country are finding creative solutions to our healthcare system challenges and these awards will continue to stimulate these ideas," said U.S. Secretary of Health and Human Services Kathleen Sebelius ... Read more
|
|
Partnerships
|
Amgen, Novartis Aim to Fuel Biotech Startups in Alliances with Atlas Venture
 "Amgen is very excited to partner with Atlas Venture, one of a small number of venture capital groups that truly focuses on creating value by translating groundbreaking science into new companies," said Dr. Sean Harper (photo right), Amgen's chief of R&D ... Learn more
|
|
Genetic Testing
|
Response Genetics Announces Contract with Blue Shield of California
 The Los Angeles-based biotech company's agreement marks its first Blue Cross Blue Shield-affiliated contract and will offer Blue Shield of California's membership access to Response Genetics' portfolio of predictive genetic testing ... Read more
|
|
Stock Performance
|
Puma Biotech Gains After Rival Drug Data
Show No Threat.
 The West Los Angeles-based Puma Biotechnology, the maker of an experimental cancer drug called neratinib, had a recent jump in stock price after data on a competitor medicine did nothing to meet analysts' expectations. The shares of Puma have risen 99% this year ... Read more
|
| Join SoCalBio | |
Become a SoCalBio Member and Save Money by Utlizing the SoCalBio Group Purchasing Program
|
|
Cancer Vaccine Patent
|
ImmunoCellular Therapeutics Announces Issuance of Key Patent Covering ICT-107 Cancer Vaccine Target
 "We believe that this issued patent will complement and extend the broad intellectual property protection we have established for two of our company's key assets, ICT-107 and ICT-140, and represents a valuable addition to our patent estate," said Andrew Gengos (photo right), ImmunoCellular Chief Executive Officer. "IL-13Rα2 is a tumor-associated antigen present in the majority of brain cancers, and we believe that using an immunotherapeutic vaccine that targets this and other specific antigens as well as cancer stem cells to stimulate an immune response represents a promising anticancer approach.... Read more
|
|
Surgical Tools
|
BioLase Gets the Nod from FDA to Market its WaterLase iPlus for Use on Soft Tissue During Orthopedic and Podiatric Procedures.
 The Irvine-based BIOLASE won FDA approval to offer its WaterLase iPlus for use on soft tissue during orthopedic and podiatric procedures. The company has been focusing on the dental market until now, and this is the first of their WaterLase systems to receive clearance for work outside the mouth ... Read more
|
|
FDA Inspection
|
A New Study by Emergo Group Shows FDA Inspections Up Under the Obama Administration
The FDA 483 warning letter data supports medical device industry claims that quality system citations have increased over the last four years. Medical device firms should expect the trend of stepped-up FDA inspections to continue through the Obama administration's second term. However, the data also provides a clear indication of which QSR quality system components most commonly draw scrutiny from inspectors; medical device manufacturers active in the US market now know to pay particular attention to their CAPA and P&PC procedures to ensure compliance with 21 CFR Part 820 ... Read more
|
|
Talent Development
|
SoCalBio Contributes to Biotech/Biopharma Talent Development in Southern California:
Industry to Develop Valley College Biomanufacturing Technician Training Program
 The San Fernando Business Journal covers the SoCalBio-initiated and DOL-funded three-year project that establishes the Community College Consortium for Biosciences Credentials. This project will be centered at Los Angeloes Valley College in the San Fernando Valley. The project's objective is to develop core bio-manufacturing competencies and introduce stackable and latticed credentials to help trade-impacted workers get new jobs..... Click here to access the article
|
| Jobs Available | |
Response Genetics (Los Angeles)
Tribogenics (Marina del Rey)
Click to access more info
BioLase (Irvine)
STAAR Surgical (Monrovia)
SynTouch LLP (Los Angeles)
Keck Graduate Institute (Claremont)
ImaginAB (Inglewood)
Absorption Systems (San Diego)
Replenish Inc. (Pasadena)
Click here for more info and to apply
- Electrical Engineer (REQ #:12-04)
- Facilities Maintenance Worker (REQ #:12-29)
- Process Engineer/MEMS Fabrication (REQ #:12-31)
- Process Development Engineer (REQ #:12-32)
- Process Development Engineer (REQ #:12-33)
Puma Biotechnology (Los Angeles)
Bioject (Orange County)
Helix Medical (Baldwin Park)
|
|
| About SoCalBio |
 SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
|
|
